Doç. Dr. Cennet Şahin
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Bone Neoplasms 5 publicationsSource: OpenAlex / PubMed MeSHView publications
- Osteoma, Osteoid 4 publications
- Breast Neoplasms 4 publications
- COVID-19 2 publications
- Pneumonia, Viral 2 publications
- Coronavirus Infections 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyRadiologysaglik.gov.trFrom source
- InstitutionŞişli Hamidiye Etfal Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workBone NeoplasmsExtracted from 5 publications · Model version —From source
- Publications38 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0002-8695-327XORCIDFrom source
- Last synchronised5 November 2026 08:56https://sislietfaleah.saglik.gov.tr/TR-1435744/doktorlarimiz.html#cennet-sahinsaglik.gov.tr
Scientific work
Publications on Bone Neoplasms
-
Evaluation of early C-reactive protein kinetics as an early response marker in biliary tract cancer patients treated with combined chemoimmunotherapy.
Journal of Clinical Oncology, 2026
DOI 10.1200/jco.2026.44.2_suppl.530 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Early C-reactive protein kinetics predict outcomes in unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors: a multicenter, observational study comparing different C-reactive protein kinetic definitions
Frontiers in Oncology, 2026
DOI 10.3389/fonc.2026.1889205 PMID 42694061 Open-access full textSource: OpenAlex
-
Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092)
Figshare, 2026
DOI 10.6084/m9.figshare.34728026 Open-access full textSource: OpenAlex
-
Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092)
Future Oncology, 2026
DOI 10.1080/14796694.2026.2748246 PMID 42902603 Open-access full textSource: OpenAlex
-
Adjuvant chemotherapy with cisplatin and gemcitabine compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1/AIO-HEP-0112 trial)
Annals of Oncology, 2026
DOI 10.1016/j.annonc.2026.10.1278 PMID 42926109 Open-access full textSource: OpenAlex
-
Evaluation of early C‐reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study
Cancer, 2026
DOI 10.1002/cncr.70644 PMID 42870461 Open-access full textSource: OpenAlex
-
Examining the relationship between personality traits, anxiety levels, and coping styles with stress among architecture students
European Psychiatry, 2025
DOI 10.1192/j.eurpsy.2025.1496 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Upgrade Rısk on Core Needle Bıopsy, Should we Contınue Excısıon of the Papıllomas of the Breast?
Indian Journal of Surgery, 2024
DOI 10.1007/s12262-023-03844-7 Source: ORCID
-
Feasibility and accuracy of targeted axillary dissection in breast cancer patients; single center experience
Frontiers in Surgery, 2024
DOI 10.3389/fsurg.2023.1332142 PMID 38269392 3 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Radiological Recovery of Osteoid Osteoma after CT Guided Percutaneous Radiofrequency Ablation
Journal of College of Physicians And Surgeons Pakistan, 2022
DOI 10.29271/jcpsp.2022.08.1056 PMID 35932133 Open-access full textSource: OpenAlex